Compugen Q2 FY26 net loss narrows to USD 7 million; revenue more than doubled to USD 2.6 million - CGEN News | RalliesCompugen Q2 FY26 net loss narrows to USD 7 million; revenue more than doubled to USD 2.6 million
C
CGEN• Q2 results
- Compugen posted a Q2 GAAP net loss of USD 7.01 million, narrowing from USD 7.34 million a year earlier.
- Revenue more than doubled to USD 2.6 million, reflecting recognition of Gilead upfront and IND milestone payments.
- R&D expenses rose 11.8% to USD 6.31 million, while G&A spending edged up to USD 2.26 million.
- Cash and cash-related balances totaled about USD 125.3 million at June 30, with runway expected to fund operations into 2029.
Pipeline update
- MAIA-ovarian interim analysis for COM701 remains on track, with median progression-free survival data expected by Q1 2027.
•
